| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/17/2002 | CN1359377A Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 07/17/2002 | CN1359295A Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug |
| 07/17/2002 | CN1359294A Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel |
| 07/17/2002 | CN1359288A Method for improvement of transport across adaptable semi-permeable barriers |
| 07/17/2002 | CN1358515A Medicine for treating diabetes and process for preparing same |
| 07/17/2002 | CN1358499A Animal phisiologicla and biological activity regulation agent composition containing cysteamine and its salt |
| 07/17/2002 | CN1358494A Composition for increasing osmosis of local skin reagent |
| 07/17/2002 | CN1358493A Process for preparing fat-reducing tablet |
| 07/17/2002 | CN1358458A Jojoba seed and its extract in use of fat prevention and banting |
| 07/17/2002 | CN1087779C Macroencapsulated secretory cells |
| 07/17/2002 | CN1087627C Medicament for treating diabetes and its preparation method |
| 07/16/2002 | US6420591 Carbamates and compositions thereof, and methods for their use for treating cancer, inflammation, or a viral infection |
| 07/16/2002 | US6420520 Peptides and remedy for bone diseases containing the same as active ingredient |
| 07/16/2002 | US6420426 Used to treat complications from diabetes mellitus |
| 07/16/2002 | US6420414 Amino derivatives of EM-138 and methods of treating angiogenesis with same |
| 07/16/2002 | US6420413 Heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds |
| 07/16/2002 | US6420409 Benzimidazole derivatives |
| 07/16/2002 | US6420385 Substituted pyrimidinone and pyridone compounds and methods of use |
| 07/16/2002 | US6420376 Amido spiropiperidines promote the release of growth hormone |
| 07/16/2002 | US6420373 9-N-Bicyclic nuceoside agents useful as selective inhibitors of proinflammatory cytokines |
| 07/16/2002 | US6420364 Treating autoimmune diseases,alzheimer's disease, atherosclerosis, osteoporosis, |
| 07/16/2002 | US6420353 Use of 7 α-substituted steroid to treat neuropsychiatric, immune or endocrine disorders |
| 07/16/2002 | US6420342 Ribose, folic acid, orotic acid |
| 07/16/2002 | US6420340 Homogeneous preparation of protein, e.g. leptin, modified at the n-terminal only by an anhydride, e.g. succinic anhydride, ethylenediaminetetraacetic dianhydride; improved solubility; no inflammation at injection sites |
| 07/16/2002 | US6420339 Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
| 07/16/2002 | US6419955 Process for making bisphosphonate compositions |
| 07/16/2002 | US6419911 Baked goods; lowering cholesterol |
| 07/16/2002 | CA2105977C Thiocarbamate sulfoxide composition for deterring ethanol ingestion |
| 07/16/2002 | CA2090009C Methods for inhibiting rejection of transplanted tissue |
| 07/11/2002 | WO2002088120A1 Method for obtaining pioglitazone as an antidiabetic agent |
| 07/11/2002 | WO2002053775A2 Identification of genetic determinants of polymorphic cyp3a5 expression |
| 07/11/2002 | WO2002053770A2 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests |
| 07/11/2002 | WO2002053742A2 Proteins and nucleic acids encoding same |
| 07/11/2002 | WO2002053738A1 Novel proteins and dnas thereof |
| 07/11/2002 | WO2002053580A2 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 07/11/2002 | WO2002053573A1 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 07/11/2002 | WO2002053568A1 Cholesterol biosynthesis inhibitors containing as the active ingredient tricyclic spiro compounds |
| 07/11/2002 | WO2002053565A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient |
| 07/11/2002 | WO2002053557A1 Novel sulfamides and their use as endothelin receptor antagonists |
| 07/11/2002 | WO2002053548A1 Benzothiazepine derivatives |
| 07/11/2002 | WO2002053547A1 Alkanoic acid derivatives, process for their production and use thereof |
| 07/11/2002 | WO2002053546A1 Heterocycle derivatives as ppar-gamma agonists |
| 07/11/2002 | WO2002053534A1 Vla-4 inhibitors |
| 07/11/2002 | WO2002053523A1 Tropolone derivative |
| 07/11/2002 | WO2002053522A2 Novel estrogen receptor ligands and methods i |
| 07/11/2002 | WO2002053519A2 Hydrophobic polyamine analogs and methods for their use |
| 07/11/2002 | WO2002053190A2 Particles for inhalation having sustained release properties |
| 07/11/2002 | WO2002053159A1 Neurotrophic tacrolimus analogs |
| 07/11/2002 | WO2002053140A2 New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents |
| 07/11/2002 | WO2002053106A2 Autoantigen composition |
| 07/11/2002 | WO2002053100A2 Pharmaceutical dosage form for oral administration of low molecular weight heparin |
| 07/11/2002 | WO2002053094A2 Method for detoxifying a carbohydrate containing solution |
| 07/11/2002 | WO2002053091A2 Medicinal combination of a biguanine (metformin) and arginine |
| 07/11/2002 | WO2002053090A2 Medicinal association of a biguanine (metformin) and arginine |
| 07/11/2002 | WO2002052957A1 Creatine/citric acid compound, method for the production of the same and the use thereof |
| 07/11/2002 | WO2002052955A1 Nutritional and therapeutical preparations having antioxidant activity |
| 07/11/2002 | WO2002039984A3 Medicine based on anti-hyperglycaemic microcapsules with prolonged release |
| 07/11/2002 | WO2002028880A8 Compounds useful for treating hypertriglyceridemia |
| 07/11/2002 | WO2002024658A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 07/11/2002 | WO2002024657A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 07/11/2002 | WO2002024632A3 Substituted aminopropoxyaryl derivatives useful as agonists for lxr |
| 07/11/2002 | WO2002020724A3 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 07/11/2002 | WO2002017914A8 Fused pyrrolocarbazoles against inflammation |
| 07/11/2002 | WO2002014511A3 Regulation of human p2y1-like g protein-coupled receptor |
| 07/11/2002 | WO2002011716A3 Liquid formulation of metformin |
| 07/11/2002 | WO2002010199A3 C3b/c4b complement receptor-like molecules and uses thereof |
| 07/11/2002 | WO2001096311A3 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases |
| 07/11/2002 | WO2001095890B1 Oral pharmaceutical compositions containing terbinafine |
| 07/11/2002 | WO2001044473A3 Polypeptides and nucleic acids encoding same |
| 07/11/2002 | WO2001043540A3 Methods for producing transgenic animals |
| 07/11/2002 | WO2001030392A3 Delivery of proteins across polar epithelial cell layers |
| 07/11/2002 | WO2001025438A3 Ifn-alpha homologues |
| 07/11/2002 | WO2001020969A3 Use of ribose to prevent cramping and soreness in muscles |
| 07/11/2002 | WO2001017568A3 Bioconjugation in vivo to pulmonary or blood components |
| 07/11/2002 | WO2001016120A9 Biaryl-oxa(thia)zole derivatives and their use as ppars modulators |
| 07/11/2002 | WO2001003680A3 Compounds for inhibiting diseases and preparing cells for transplantation |
| 07/11/2002 | WO2000064911A9 Ligands for metabotropic glutamate receptors |
| 07/11/2002 | US20020091266 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 07/11/2002 | US20020091263 Biaryl substituted purine derivatives as potent antiproliferative agents |
| 07/11/2002 | US20020091240 Humanized antibodies to gamma-interferon |
| 07/11/2002 | US20020091143 Use of 4-substituted tetrahydropyridines for the manufacture of medicament s acting upon TGF-beta 1 |
| 07/11/2002 | US20020091128 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 07/11/2002 | US20020091121 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 07/11/2002 | US20020091110 Dietary compositions |
| 07/11/2002 | US20020091109 Also for treating malignant tumors, rheumatoid arthritis, osteoporosis, diabetes mellitus, hypertension, alopecia, acne, psoriasis, dermatitis, hypercalcemia, hypoparathyroidism and metabolic disorder of cartilage. |
| 07/11/2002 | US20020091105 Useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. |
| 07/11/2002 | US20020091104 Protein tyrosine phosphatases inhibitors, especially as antidiabetic agents |
| 07/11/2002 | US20020091078 Treating diabetes, especially Type II diabetes |
| 07/11/2002 | US20020090622 Detection of a polymorphism in a sodium transport protein; obtain sample, recover nucleotide sequences from sample, determine nucleotide sequences of sample, compare to control |
| 07/11/2002 | US20020090404 Therapy of atherosclerosis and hypercholesterolemia with canola extracts |
| 07/11/2002 | US20020090379 Poviding self-protein analog by molecular biological means by substitution of one or more peptide fragments of self-protein by corresponding number of peptides known to contain immunodominant foreign T-cell epitopes |
| 07/11/2002 | US20020090373 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof |
| 07/11/2002 | US20020090371 Orally or enterally administering to the mammal an effective immunosuppressive dose of a plant material derived from a plant transformant capable of producing antigen or an immunosuppressive fragment or its derivative |
| 07/11/2002 | CA2435484A1 Medicinal association of a biguanide (metformin) and a carrier agent (arginine) |
| 07/11/2002 | CA2435483A1 Use as medicine of a compound restoring active principles in vivo |
| 07/11/2002 | CA2433828A1 Novel estrogen receptor ligands and methods i |
| 07/11/2002 | CA2433782A1 Proteins and nucleic acids encoding same |
| 07/11/2002 | CA2433779A1 Heterocycle derivatives as ppar-gamma agonists |
| 07/11/2002 | CA2433573A1 Alkanoic acid derivatives, process for their production and use thereof |
| 07/11/2002 | CA2433384A1 Neurotrophic tacrolimus analogs |